Journal of General Virology, Vol 79, 2137-2146, Copyright © 1998 by Society for General Microbiology

ARTICLES

Mutant canine oral papillomavirus L1 capsid proteins which form virus- like particles but lack native conformational epitopes

Y Chen, SJ Ghim, AB Jenson and R Schlegel
Department of Pathology, Georgetown University Medical Center, Washington, DC 20007, USA.

Recently, the L1 capsid protein of canine oral papillomavirus (COPV) has been used as an effective systemic vaccine that prevents viral infections of the oral mucosa. The efficacy of this vaccine is critically dependent upon native L1 conformation and, when purified from Sf9 insect cells, the L1 protein not only displays type-specific, conformation-dependent epitopes but it also assembles spontaneously into virus-like particles (VLPs). To determine whether VLP formation was coupled to the expression of conformation-dependent epitopes, we generated a series of N- and C-terminal L1 deletion mutants and evaluated their ability to form VLPs (by electron microscopy) and to react with conformation-dependent antibodies (by immunofluorescence microscopy). We found that (a) deletion of the 26 C-terminal residues generated a mutant protein which formed VLPs efficiently and folded correctly both in the cytoplasm and in the nucleus; (b) further truncation of the L1 C terminus (67 amino acids) resulted in a capsid protein which formed VLPs but which failed to express conformational epitopes; (c) deletion of the first 25 N-terminal amino acids also abolished expression of conformational epitopes (without altering VLP formation) but the native conformation of this deletion mutant could be restored by the addition of the human papillomavirus type 11 N terminus. These results demonstrate that VLP formation and conformational epitope expression can be dissociated and that the L1 N terminus has a critical role in protein folding. In addition, it appears that correct L1 protein folding is not dependent upon the nucleoplasmic environment.

This article has been cited by other articles:

				M. Berg, J. DiFatta, E. Hoiczyk, R. Schlegel, and G. Ketner Viable adenovirus vaccine prototypes: High-level production of a papillomavirus capsid antigen from the major late transcriptional unit PNAS, March 22, 2005; 102(12): 4590 - 4595. [Abstract] [Full Text] [PDF]

				H. Yuan, P. A. Estes, Y. Chen, J. Newsome, V. A. Olcese, R. L. Garcea, and R. Schlegel Immunization with a Pentameric L1 Fusion Protein Protects against Papillomavirus Infection J. Virol., September 1, 2001; 75(17): 7848 - 7853. [Abstract] [Full Text] [PDF]

				B. Ma, C.-J. Tsai, and R. Nussinov Binding and folding: in search of intramolecular chaperone-like building block fragments Protein Eng. Des. Sel., September 1, 2000; 13(9): 617 - 627. [Abstract] [Full Text] [PDF]

				G. Sibbet, C. Romero-Graillet, G. Meneguzzi, and M. S. Campo {alpha}6 integrin is not the obligatory cell receptor for bovine papillomavirus type 4 J. Gen. Virol., February 1, 2000; 81(2): 327 - 334. [Abstract] [Full Text]